Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated With Second-Generation Drug-Eluting Stents

The purpose of the study was to evaluate the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention, especially in the era of second-generation drug-eluting stents (DES). The work was conducted from November 2014 to April 2015. All randomized controlled trials...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2016-06, Vol.117 (11), p.1714-1723
Hauptverfasser: D'Ascenzo, Fabrizio, MD, Moretti, Claudio, MD, Bianco, Matteo, MD, Bernardi, Alessandro, MD, Taha, MD, Salma, Cerrato, Enrico, MD, Omedè, Pierluigi, MD, Montefusco, Antonio, MD, Frangieh, Antonio H., MD, Lee, Cheol W., MD, Campo, Gianluca, MD, Chieffo, Alaide, MD, Quadri, Giorgio, MD, Pavani, Marco, MD, Zoccai, Giuseppe B., MD, Gaita, Fiorenzo, MD, Park, Seung-Jung, MD, Colombo, Antonio, MD, Templin, Christian, MD, Lüscher, Thomas F., MD, Stone, Gregg W., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The purpose of the study was to evaluate the optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention, especially in the era of second-generation drug-eluting stents (DES). The work was conducted from November 2014 to April 2015. All randomized controlled trials comparing short (
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2016.03.005